Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation

v3.22.2.2
Stock-based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

4. Stock-based Compensation

 

The Company recognized stock-based compensation on all employee and non-employee awards as follows:

 

   

For the Three

Months Ended

September 30, 2022

   

For the Three

Months Ended

September 30, 2021

   

For the Nine

Months Ended

September 30, 2022

   

For the Nine

Months Ended

September 30, 2021

 
Research and development   $ 32,297     $ 38,946     $ 98,151     $ 118,634  
General and administrative     436,248       61,823       739,629       1,337,036  
Total Stock-based compensation   $ 468,545     $ 100,769     $ 837,780     $ 1,455,670  

 

The following table summarizes the stock option activity during the nine months ended September 30, 2022:

 

    Number of Shares    

Weighted Average

Exercise Price

    Weighted Average Remaining Contractual Term (In Years)    

Aggregate

Intrinsic Value(1)

 
Outstanding at December 31, 2021     6,724,402     $ 0.95       7.99     $ 2,773  
Granted     2,952,500       0.34           $  
Exercised                     $  
Expired     (4,500 )     12.00                  
Forfeited     (726,998 )     0.94           $  
Outstanding at September 30, 2022     8,945,404     $ 0.68       8.16     $  
                                 
Exercisable at September 30, 2022     6,832,900     $ 0.77       7.79     $  

 

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2021 and September 30, 2022, respectively.

 

Total unrecognized compensation cost related to unvested stock options was $517,724 as of September 30, 2022 and is expected to be recognized over a weighted-average period of less than two years.

 

On February 25, 2022, the Company held its reconvened 2020 Annual Meeting. At the reconvened 2020Annual Meeting, the shareholders of the Company approved and ratified the Company’s 2021 Equity Incentive Plan (the “2021 Plan”) which is a successor to the Company’s 2012 Equity Incentive Plan (the “2012 Plan”).The 2021 Plan provides the aggregate number of shares of Common Stock that may be issued under the 2021 Plan will not exceed the sum of (i) 10,000,000 new shares, (ii) the number of shares remaining available for the grant of new awards under the 2012 Plan as of immediately prior to the effective date of the 2021 Plan, and (iii) certain shares subject to outstanding awards granted under the 2012 Plan that may become available for issuance under the 2021 Plan, as such shares become available from time to time. As of September 30, 2022, 9,877,306 shares of common stock are available for future awards under the 2021 Plan.

 

Each executive officer and non-employee director receiving equity-based awards is subject to a minimum dollar value stock ownership holding requirement with respect to the awards received as well as all prior equity awards under the 2021 Plan which requirements are intended to align the ability to sell shares with the performance of the Company’s stock price. The executive officer recipients each have a minimum dollar value stock ownership holding requirement threshold equal to two times (2x) their then base salaries below which dollar threshold they would be precluded from selling any shares of Company stock obtained from the Company under its 2021 Plan. Also, the non-employee directors are each subject to a minimum dollar value stock ownership holding requirement threshold equal to six times the annual Board retainer ($270,000) below which dollar threshold they would be precluded from selling shares of Company stock acquired from the Company under its 2021 Plan.